Charles River Laboratories International (CNSX:CRL) and Volpara Health Technologies (ASX:VHT) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.
Profitability
This table compares Charles River Laboratories International and Volpara Health Technologies' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Charles River Laboratories International | N/A | N/A | N/A |
Volpara Health Technologies | N/A | N/A | N/A |
Valuation and Earnings
This table compares Charles River Laboratories International and Volpara Health Technologies' gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Charles River Laboratories International | N/A | N/A | N/A | N/A | N/A |
Volpara Health Technologies | $15.22 million | 0.00 | $-21,336,615.68 | A($0.09) | N/A |
Charles River Laboratories International has higher earnings, but lower revenue than Volpara Health Technologies.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Charles River Laboratories International and Volpara Health Technologies, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Charles River Laboratories International | 0 | 0 | 0 | 0 | N/A |
Volpara Health Technologies | 0 | 0 | 0 | 0 | N/A |
Summary
Volpara Health Technologies beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.